Last reviewed · How we verify
Locally Directed Therapy — Competitive Intelligence Brief
phase 3
Oncology
Small molecule
Live · refreshed every 30 min
Target snapshot
Locally Directed Therapy (Locally Directed Therapy) — National Cancer Institute (NCI). Locally directed therapy delivers therapeutic agents directly to tumor sites to maximize local drug concentration while minimizing systemic exposure.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Locally Directed Therapy TARGET | Locally Directed Therapy | National Cancer Institute (NCI) | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Locally Directed Therapy CI watch — RSS
- Locally Directed Therapy CI watch — Atom
- Locally Directed Therapy CI watch — JSON
- Locally Directed Therapy alone — RSS
Cite this brief
Drug Landscape (2026). Locally Directed Therapy — Competitive Intelligence Brief. https://druglandscape.com/ci/locally-directed-therapy. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab